Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Most discussed topics
Brands & references
Total monthly reach
Estimated from 3 chart positions in 3 markets.
By chart position
- 🇬🇷GR · Medicine#1430K to 100K
- 🇦🇪AE · Medicine#2610K to 30K
- 🇨🇴CO · Medicine#633K to 10K
- Per-Episode Audience
Est. listeners per new episode within ~30 days
22K to 70K🎙 Weekly cadence·62 episodes·Last published today - Monthly Reach
Unique listeners across all episodes (30 days)
43K to 140K🇬🇷71%🇦🇪21%🇨🇴7% - Active Followers
Loyal subscribers who consistently listen
13K to 42K
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
From 11 epsHosts
Not detected.
Recent guests
Recent episodes
Ask us anything about… pharmacovigilance careers!
Jun 25, 2026
1m 00s
#46 Protecting the health ecosystem – Valentina Giunchi & Joe Mitchell
Jun 4, 2026
35m 05s
#45 How to perform better disproportionality analyses – Michele Fusaroli & Eugene van Puijenbroek
Mar 26, 2026
47m 20s
#44 Rethinking medical device safety, part 2 – Omar Aimer
Feb 26, 2026
21m 22s
#43 Rethinking medical device safety, part 1 – Omar Aimer
Jan 28, 2026
22m 44s
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Topics | Guests | Brands | Places | Keywords | Sponsor | Length | |
|---|---|---|---|---|---|---|---|---|---|
| 6/25/26 | Ask us anything about… pharmacovigilance careers! | Send a message to the show! From signal assessor to researcher, QPPV and more, pharmacovigilance specialists play vital roles that differ widely based on their organisation and job title. But where should you begin if you're just starting your career or trying to break into the field? For our next episode, we will be chatting to Myriam Salem, national compliance and enforcement supervisor at Health Canada, and Francesco Salvo, professor and pharmacologist at Université de Bordeaux, about care... | 1m 00s | ||||||
| 6/4/26 | #46 Protecting the health ecosystem – Valentina Giunchi & Joe Mitchell✨ | ecopharmacovigilanceOne Health+3 | Valentina GiunchiJoe Mitchell | Uppsala Monitoring Centre | — | pharmacovigilanceecopharmacovigilance+3 | — | 35m 05s | |
| 3/26/26 | #45 How to perform better disproportionality analyses – Michele Fusaroli & Eugene van Puijenbroek✨ | disproportionality analysisbiases+2 | Michele FusaroliEugene van Puijenbroek | Uppsala Monitoring CentreLareb | Netherlands | pharmacovigilancedata analysis+1 | — | 47m 20s | |
| 2/26/26 | #44 Rethinking medical device safety, part 2 – Omar Aimer✨ | medical device safetypharmacovigilance+3 | Omar Aimer | ISoPthe Medical Device Safety Special Interest Group | — | medical devicessafety monitoring+2 | — | 21m 22s | |
| 1/28/26 | #43 Rethinking medical device safety, part 1 – Omar Aimer✨ | medical device safetypharmacovigilance+2 | Omar Aimer | ISoPthe Medical Device Safety Special Interest Group | — | medical devicespatient safety+1 | — | 22m 44s | |
| 12/16/25 | #42 Unpacking the WHO Global Smart Pharmacovigilance Strategy – Shanthi Pal✨ | pharmacovigilanceWHO+3 | Shanthi Pal | WHO | CairoEgypt | CairoAnnual Meeting+1 | — | 18m 43s | |
| 11/21/25 | #41 How to use artificial intelligence in pharmacovigilance, part 2 – Niklas Norén✨ | artificial intelligencepharmacovigilance+2 | Niklas Norén | Uppsala Monitoring Centre | — | generative AItrust+1 | — | 29m 48s | |
| 10/17/25 | #40 How to use artificial intelligence in pharmacovigilance, part 1 – Niklas Norén✨ | artificial intelligencepharmacovigilance+2 | Niklas Norén | ResearchUppsala Monitoring Centre | — | generative AIcase processing+2 | — | 29m 40s | |
| 8/29/25 | #39 Putting children first on Patient Safety Day – Angela Caro-Rojas✨ | patient safetypaediatric pharmacovigilance+2 | Angela Caro-Rojas | ISoP | — | World Patient Safety Daychildren's healthcare+1 | — | 26m 16s | |
| 6/19/25 | #38 Patient perspectives in PV: a fireside chat at the ISoP mid-year symposium✨ | pharmacovigilancepatient perspectives+1 | Angela Caro-RojasLinda Härmark+1 | ISoPthe International Society of Pharmacovigilance+1 | UppsalaSweden+1 | ISoPsymposium+2 | — | 35m 23s | |
Want analysis for the episodes below?Free for Pro Submit a request, we'll have your selected episodes analyzed within an hour. Free, at no cost to you, for Pro users. | |||||||||
| 5/28/25 | #37 Beyond numbers: quality in ADR reporting – Henry Zakumumpa✨ | adverse event reportingpharmacovigilance+2 | Henry Zakumumpa | — | Uganda | quality reportshealthcare professionals+2 | — | 39m 28s | |
| 3/27/25 | #36 Pregnancy-related pharmacovigilance – Levente Pápai, Lovisa Sandberg & Sara Vidlin✨ | pregnancypharmacovigilance+2 | Levente PápaiLovisa Sandberg+1 | Uppsala Monitoring Centre | — | medical productssafety profiles+1 | — | 37m 23s | |
| 1/28/25 | #35 Veterinary pharmacovigilance, part 2 – James Mount | Send a message to the show! Human and veterinary pharmacovigilance (PV) share many goals, challenges and approaches. But there are also significant differences, such as the numerous animal species that veterinary PV needs to take into account. In this two-part episode of Drug Safety Matters, James Mount, Veterinary Pharmacovigilance assessor at the Swedish Medical Products Agency, and EU elected chair of the Pharmacovigilance Working Party for veterinary medicinal products, joins the show to ... | 42m 27s | ||||||
| 12/17/24 | #34 Veterinary pharmacovigilance, part 1 – James Mount | Send a message to the show! Human and veterinary pharmacovigilance (PV) share many goals, challenges and approaches. But there are also significant differences, such as the numerous species and breeds that veterinary PV needs to take into account. In this two-part episode of Drug Safety Matters, James Mount, Veterinary Pharmacovigilance assessor at the Swedish Medical Products Agency, and EU elected chair of the Pharmacovigilance Working Party for veterinary medicinal products, joins the show... | 48m 06s | ||||||
| 11/29/24 | #33 Narrative fields and signal assessors, an exploratory study – Joana Félix and Alem Zekarias | Send a message to the show! While structured data elements such as patient identifier, medicine name and reaction, are fundamental for adverse event reporting, they may not capture all relevant details. This is where the narrative fields come in, allowing reporters to disclose important contextual information, such as the patient’s full clinical course. But how do PV assessors interact with these narratives in spontaneous reports? What needs and challenges do they experience? These and other ... | 39m 28s | ||||||
| 10/25/24 | #32 Pharmacovigilance in older adults – Giovanni Furlan | Send a message to the show! Medication-related-harm (MRH) is especially prevalent in older adults due to changing physiology as the body ages, increased frailty, and the incidence of polypharmacy in this patient group. Giovanni Furlan, Worldwide Safety Site Lead for Thessaloniki of Pfizer discusses what makes this patient group so vulnerable to adverse drug reactions, how poor representation and using age alone to define older adults exacerbates this problem, and suggests ways forward in moni... | 48m 36s | ||||||
| 9/30/24 | #31 A guide to reporting disproportionality analyses – Michele Fusaroli and Daniele Sartori | Send a message to the show! Disproportionality analyses are a mainstay of pharmacovigilance research, but without clear guidelines, they often lead to confusion and misinterpretation. Enter the READUS-PV statement: the first-ever guide for reporting disproportionality analyses that are replicable, reliable, and reproducible. Tune in to find out: The history of reporting guidelines in pharmacovigilance and why the READUS-PV guidelines were created Why there has been a spike i... | 43m 30s | ||||||
| 8/26/24 | Uppsala Reports Long Reads – Weeding out duplicates to better detect side effects | Send a message to the show! Duplicate reports are a big problem when it comes to signal detection, but with the help of machine learning and new ways of comparing reports, we may more effectively detect them. This episode is part of the Uppsala Reports Long Reads series – the most topical stories from UMC’s pharmacovigilance news site, brought to you in audio format. Find the original article here. After the read, we speak to author Jim Barrett, Senior Data Scientist at UMC, to learn mo... | 25m 48s | ||||||
| 6/27/24 | Uppsala Reports Long Reads – Ensuring trust in AI/ML when used in pharmacovigilance | Send a message to the show! Ensuring trust in AI is vital to fully reap the benefits of the technology in pharmacovigilance. Yet, how do we do so while grappling with its ever-growing complexity? This episode is part of the Uppsala Reports Long Reads series – the most topical stories from UMC’s pharmacovigilance news site, brought to you in audio format. Find the original article here. After the read, we speak to one of the authors of the article, Michael Glaser, to learn more about how AI an... | 31m 03s | ||||||
| 5/15/24 | #30 Preventing and reporting medication errors – Rabat CC & UMC | Send a message to the show! Look-alike medicines, unclear communication and distractions during administration – medication errors may occur for many different reasons. They all have in common that they are unintended mistakes in the drug treatment process that may or may not lead to patient harm. In this episode Ghita Benabdallah and Loubna Alj from the national pharmacovigilance centre of Morocco, and Alem Zekarias from Uppsala Monitoring Centre discuss how we can prevent medication errors ... | 34m 43s | ||||||
| 4/23/24 | #29 When medicines change our behaviour – Michele Fusaroli | Send a message to the show! Medicines can affect our personality in positive ways, but they may also lead to destructive behaviours that can damage our relationships, finances, and overall quality of life. Michele Fusaroli from the University of Bologna explains how to diagnose and treat drug-induced impulse control disorders. Tune in to find out: Which medicines may cause impulsivityWhat the ‘four knights’ of impulsivity areHow patient stories can help detect these conditionsWant to know mor... | 31m 15s | ||||||
| 2/29/24 | #28 Catching black swans – François Montastruc | Send a message to the show! Serious and unexpected adverse drug reactions – the ‘black swans’ of pharmacovigilance – can place enormous strain on safety monitoring systems. Drawing examples from the COVID-19 pandemic, François Montastruc from Toulouse University Hospital explains how we can get better at dealing with the unpredictable. Tune in to find out: What Nassim Nicholas Taleb’s ‘black swan’ theory has to do with pharmacovigilanceWhat makes an adverse drug reaction a black, white, or gr... | 28m 06s | ||||||
| 2/1/24 | #27 When drugs damage the liver – Rita Baião | Send a message to the show! The liver is the primary site for drug metabolism in the body, but it can be severely damaged by medicines or their toxic compounds. Rita Baião from the North Lisbon University Hospital Center reviews what pharmacovigilance professionals should know about drug-induced liver injury (DILI). Tune in to find out: Who is most at risk of developing DILIHow to diagnose the condition and control the damageHow to assess case reports of DILIWant to know more? This infograph... | 29m 15s | ||||||
| 12/20/23 | #26 What's trending in pharmacovigilance? – Angela Caro-Rojas | Send a message to the show! What did the drug safety community achieve in 2023 and how will the field develop in 2024? As the year comes to a close, we asked Angela Caro-Rojas, president of the International Society of Pharmacovigilance (ISoP), to walk us through current and future trends in pharmacovigilance. Tune in to find out: Why patient engagement is a growing priorityWhat challenges exist in the Latin American regionWhich topics will be in the spotlight next yearWant to know more? ISoP... | 28m 51s | ||||||
| 11/13/23 | #25 A week in the name of medicines safety – part 2 | Send a message to the show! To mark #MedSafetyWeek, which took place from 6–12 November, we’re releasing a special two-part episode on pharmacovigilance communication campaigns. In this second part, we hear from three #MedSafetyWeek veterans – Anne-Cécile Vuillemin from the Ministry of Health in Luxembourg, Ban Al-Shimran from the Iraqi Ministry of Health, and Frieda Shigwedha from the Therapeutic Information and Pharmacovigilance Centre in Namibia – about what makes a successful campaign. Tu... | 33m 58s | ||||||
Showing 25 of 64
Pitch Fit is a Pro feature
See how bookable this show is for guests, which brands already advertise, the per-episode ad value, and the best-fit guest and sponsor profile. The numbers are blurred on the free plan.
How readily this show books outside guests like you.
How proven this show is for host-read sponsorships.
For Guests
ProFor Advertisers
ProUpgrade to Pro to unlock guest cadence, sponsor categories, fit scores, and per-episode ad value for this show.
Chart Positions
5 placements across 3 markets.
Chart Positions
5 placements across 3 markets.